ABSTRACT
Since its appearance over 15 years ago, the successful applications of pharmacophore-based virtual screening (VS) are appearing in a steady stream. A casual perusal of recent years of
Journal of Medicinal Chemistry
alone indicates that such successes are being reported at the rate of approximately 2 to 3 per year, with publications primarily from the pharmaceutical industry, but increasingly from academic settings.
